SweetValueLab
Write for us

Labcorp Holdings Inc. — Financial Statements & Ratios

LH
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0000920148labcorp.comAbout LH
Last close · Oct 16, 2026317.95−7.12 (−2.19%)
Market cap$25.8B

Key indicators

Revenue14.3BTTM+6.4% on a year earlier+3.0% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
11.3B 11.6B+2.0%14.0B+21.0%13.1B−6.0%11.9B−9.7%12.2B+2.5%13.0B+7.0%14.0B+7.2%14.3B+6.4%14.8B 15.5B 16.2B
— 2.0% 21.0% -6.0% -9.7% 2.5% 7.0% 7.2% 6.4% 5.7% 4.9% 5.0%
$8.61 $8.36−2.9%$15.88+90.0%$24.38+53.5%$13.96−42.7%$4.77−65.8%$8.84+85.3%$10.46+18.3%$12.09+33.3%$18.35 $19.83 $21.60
Profitability
28.0% 28.1%+0.1 pt35.4%+7.3 pt38.0%+2.6 pt31.3%−6.7 pt27.7%−3.6 pt27.9%+0.2 pt26.8%−1.1 pt26.9%−1.2 pt· · ·
11.7% 11.5%−0.2 pt17.5%+6.0 pt23.2%+5.7 pt12.1%−11.1 pt6.0%−6.1 pt8.4%+2.4 pt10.9%+2.5 pt11.3%+2.5 pt· · ·
7.8% 7.1%−0.7 pt11.1%+4.0 pt18.1%+7.0 pt10.8%−7.3 pt3.4%−7.3 pt5.7%+2.3 pt6.3%+0.5 pt7.0%+1.3 pt· · ·
12.7% 10.9%−1.8 pt16.5%+5.6 pt23.1%+6.7 pt12.7%−10.5 pt5.3%−7.4 pt9.3%+4.0 pt10.2%+0.9 pt— · · ·
Cash
925.6M 1.0B+12.8%1.8B+67.9%2.6B+51.1%1.5B−44.4%874.1M−40.7%1.1B+25.4%1.2B+10.0%1.2B−8.4%· · ·
8.2% 9.0%+0.9 pt12.5%+3.5 pt20.2%+7.6 pt12.4%−7.7 pt7.2%−5.2 pt8.4%+1.2 pt8.6%+0.2 pt8.1%−1.3 pt· · ·
700.0M 450.0M−35.7%134.5M−70.1%1.7B+1175.8%1.3B−21.6%1.3B−3.9%493.2M−61.9%690.7M+40.0%— · · ·
Balance sheet
0.87x 0.94x+0.07x0.72x−0.22x0.62x−0.10x0.62x+0.00x0.76x+0.14x0.90x+0.15x0.84x−0.07x0.68x+0.08x· · ·
102.60M 98.60M−3.9%98.00M−0.6%97.50M−0.5%91.60M−6.1%87.60M−4.4%84.40M−3.7%83.80M−0.7%82.00M−2.3%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 30, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.